Quotient BioResearch Limited, the leading provider of analytical and safety evaluation services and products for bioscience and sport, announces that following the recent acquisitions of HFL Limited, GR Micro Limited and BioDynamics Research Limited, it is consolidating its drug development services businesses under the name Quotient Bioresearch and renaming the parent company of the Group Quotient Bioscience Limited ("Quotient Bioscience").